I-Lumen Scientific Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B
  • (In Progress)

  • Investors
  • 4

I-Lumen Scientific General Information

Description

Developer of non-invasive bioelectric stimulation therapy designed for the treatment of dry age-related macular degeneration. The company develops a bioelectric stimulation system that delivers electrical pulses to the retina to support transepithelial potential and improve retinal pigment epithelium function, enabling ophthalmologists to provide office-based treatment options that aim to improve visual acuity in patients.

Contact Information

Website
www.i-lumen.com
Formerly Known As
AmeriVision International
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3800 American Boulevard, West
  • Suite 1500
  • Bloomington, MN 55431
  • United States
+1 (833)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 3800 American Boulevard, West
  • Suite 1500
  • Bloomington, MN 55431
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

I-Lumen Scientific Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 08-May-2026 In Progress Clinical Trials - General
3. Secondary Transaction - Private Completed Clinical Trials - General
2. Later Stage VC (Series A2) 15-Nov-2022 $17.6M $18.4M Completed Clinical Trials - General
1. Early Stage VC (Series A1) 06-Nov-2019 $800K $800K Completed Product In Beta Test
To view I-Lumen Scientific’s complete valuation and funding history, request access »

I-Lumen Scientific Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
To view I-Lumen Scientific’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

I-Lumen Scientific Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-invasive bioelectric stimulation therapy designed for the treatment of dry age-related macular degenera
Other Pharmaceuticals and Biotechnology
Bloomington, MN
10 As of 2025

Poulsbo, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

I-Lumen Scientific Competitors (1)

One of I-Lumen Scientific’s competitors is LumiThera, a Formerly VC-backed company based in Poulsbo, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LumiThera Formerly VC-backed Poulsbo, WA
You’re viewing 1 of 1 competitors. Get the full list »

I-Lumen Scientific Patents

I-Lumen Scientific Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260355504-A1 Medical electrode Pending 21-Jul-2026
US-20260077197-A1 Systems and methods for ocular microstimulation therapy Pending 01-Feb-2024
WO-2025166287-A1 Systems and methods for ocular microstimulation therapy Pending 01-Feb-2024
US-12589243-B2 Ocular devices and controller interfaces for ocular therapy Active 21-Oct-2022
US-20240226555-A9 Ocular devices and controller interfaces for ocular therapy Active 21-Oct-2022 A61N1/36046
To view I-Lumen Scientific’s complete patent history, request access »

I-Lumen Scientific Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

I-Lumen Scientific Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bios Partners Venture Capital Minority
MedFocus Venture Capital Minority
Wexford Capital Asset Manager Minority
K2X Venture Capital Minority
To view I-Lumen Scientific’s complete investors history, request access »

I-Lumen Scientific FAQs

  • When was I-Lumen Scientific founded?

    I-Lumen Scientific was founded in 2015.

  • Where is I-Lumen Scientific headquartered?

    I-Lumen Scientific is headquartered in Bloomington, MN.

  • What is the size of I-Lumen Scientific?

    I-Lumen Scientific has 10 total employees.

  • What industry is I-Lumen Scientific in?

    I-Lumen Scientific’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is I-Lumen Scientific a private or public company?

    I-Lumen Scientific is a Private company.

  • What is I-Lumen Scientific’s current revenue?

    The current revenue for I-Lumen Scientific is .

  • How much funding has I-Lumen Scientific raised over time?

    I-Lumen Scientific has raised $18.4M.

  • Who are I-Lumen Scientific’s investors?

    Bios Partners, MedFocus, Wexford Capital, and K2X have invested in I-Lumen Scientific.

  • Who are I-Lumen Scientific’s competitors?

    LumiThera is a competitor of I-Lumen Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process